Cristina García

Cristina García

Auto-generated profile, based on publicly available information

Cristina García

Deparment of Oncology, Universidad Alfonso X el Sabio (UAX), Avenida de la Universidad 1, Villanueva de la Cañada, 28691 Madrid, Spain

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 November 2025 in Veterinary Sciences
Verified
Journal Article
Open access
PDF file
NCNoemí Del Castillo
Noemí Del Castillo
MFManuel Fuertes-Recuero
Manuel Fuertes-Recuero
EAElisabetta De Angelis
Elisabetta De Angelis
CFClaudia de la Riva Fraga
Claudia de la Riva Fraga
CGCristina García
Cristina García
Gustavo Ortiz-DíezGustavo Ortiz-Díez
Gustavo Ortiz-Díez
This retrospective case series describes 21 dogs with stage II splenic haemangiosarcoma (HSA) and spontaneous haemoabdomen treated with splenectomy followed by a doxorubicin–cyclophosphamide protocol. Median overall survival was 92 days, with longer survival observed in dogs completing three or more chemotherapy cycles. The regimen was well tolerated, with low haematological and gastrointestinal toxicity. Maintenance metronomic chemotherapy was administered in a small subset, and it was associated with prolonged survival. While the sample size is modest, the homogeneous and clinically specific cohort provides hypothesis-generating observations on feasibility, tolerability, and time-aware associations that warrant cautious interpretation and prospective confirmation. No clinical or laboratory variable at diagnosis was independently associated with outcome. While limited by retrospective design and small sample size, this study provides focused data on a specific clinical presentation and supports the feasibility of structured adjuvant treatment in dogs with splenic HSA and haemoabdomen.